Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "inhibitor of growth family, X-linked" (INGX) is a non-canonical or erroneous designation; all credible sources and genomic nomenclature point to five recognized ING family genes. Most references to "ING1-like" or "INGX" correspond incorrectly or ambiguously to ING2 or a general ING family member, not a distinct, X-linked protein. Inhibitor of growth family member 2 (ING2) is a chromatin-binding tumor suppressor protein in the ING family. It is characterized by a plant homeodomain (PHD), interacts with histone H3K4 trimethyl marks, and associates with the HDAC-SIN3A complex to regulate transcription, chromatin structure, DNA repair, and cell cycle control. ING2 promotes cellular senescence and apoptosis, and loss-of-function mutations or reduced expression are linked to increased genomic instability and various cancers. ING2 also localizes to mitochondria, suggesting broader roles in cell metabolism and integrity. The designation "INGX," "ING1-like," or "ING1-like tumor suppressor protein" is incorrect or outdated and should be replaced by "inhibitor of growth family member 2 (ING2)" for canonical nomenclature.
Drugs could act via modulation of histone deacetylase (HDAC) complexes that ING2 associates with, affecting gene silencing or chromatin remodeling. Potential future drugs might modulate ING2's tumor suppressor or DNA stabilization functions indirectly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibitor of growth family member 2 (ING2).